Military psychology : the official journal of the Division of Military Psychology, American Psychological Association
2024
Stacey B. Armstrong, Yitong Xin, Nathan D. Sepeda et al.
19 citations
This study evaluated prospective associations of ibogaine and 5-MeO-DMT treatment for risky alcohol use and post-traumatic stress disorder (PTSD) symptoms among United States (US) Special Operations Forces Veterans (SOFV). Data were collected during standard clinical operations at pre-treatment and 1-month (1 m), 3-months (3 m), and 6-months (6 m) post-treatment in an ibogaine and 5-MeO-DMT...
Frontiers in Psychology
December 6, 2018
Rafael Lancelotta, Austin-Marley Windham-Herman, Kristel Peterson et al.
80 citations
5-MeO-DMT is a psychoactive substance found in high concentrations in the bufotoxin of the Colorado River Toad (Bufo alvarius). Emerging evidence suggests that vaporized 5-MeO-DMT may occasion mystical experiences of comparable intensity to those occasioned by more widely studied psychedelics such as psilocybin, but no empirical study has tested this hypothesis. Data was obtained from 20...
Journal of Psychedelic Studies
June 1, 2018
Thaddeus James Camlin, Donald Eulert, A. Thomas Horvath et al.
21 citations
This study examined the lived experience of individuals who underwent ibogaine treatment for an opioid use disorder. Semi-structured interview questions probed for potential changes in predetermined categories derived from a literature review. Participants' experiences with ibogaine were analyzed for commonalities and emergent themes. Categories that emerged revealed themes about subjective...
Journal of Psychoactive Drugs
2018
Benjamin Malcolm, Martin Polanco, Joseph P Barsuglia
64 citations
Opioid use disorder (OUD) is currently an epidemic in the United States (US) and ibogaine is reported to have the ability to interrupt opioid addiction by simultaneously mitigating withdrawal and craving symptoms. This study examined opioid withdrawal and drug craving scores in 50 participants with OUD undergoing a week-long detoxification treatment protocol with ibogaine. The Addiction...
Progress in Brain Research
2018
Joseph P Barsuglia, Martin Polanco, Robert Palmer et al.
37 citations
Ibogaine is a plant-derived alkaloid and dissociative psychedelic that demonstrates anti-addictive properties with several substances of abuse, including alcohol. 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a naturally occurring psychedelic known to occasion potent mystical-type experiences and also demonstrates anti-addictive properties. The potential therapeutic effects of both compounds...
Journal of Psychoactive Drugs
2018
Alan K. Davis, Elise Renn, Austin-Marley Windham-Herman et al.
34 citations
We examined persisting effects, self-perceived challenges, and potential benefits associated with positive outcomes following ibogaine detoxification using data collected as part of a larger online retrospective study of 73 patients who received treatment for chronic opioid use in Mexico between 2012 and 2015. A mixed-methods design was used comparing treatment responders versus non-responders,...
Journal of Psychedelic Studies
November 1, 2017
Alan K. Davis, Joseph P Barsuglia, Austin-Marley Windham-Herman et al.
60 citations
Very few studies have reported the effectiveness of ibogaine as a treatment for chronic opioid use. Therefore, this study evaluated the acute subjective effects of ibogaine, outcomes on problematic opioid consumption, and the long-term associations with psychological functioning. Using online data collection, 88 patients who received ibogaine treatment in Mexico between 2012 and 2015 completed...